This mechanism has been shown to contribute to the immunological killing of tumor cells; if the cancer cell expresses GSDME, an NK or CD8+ T-cell can induce it to undergo explosive pyroptotic death, thereby alerting the immune system and possibly improving antigen release for cross-priming (25, 26). This evidence concerns the gene GSDME and cancer.